Vaccine Knowledge, Attitudes and Practices Among Men Who Have Sex With Men: a Global Cross-sectional Study (VAC-M)
This study aims to investigate vaccine-related knowledge, attitude, vaccine confidence and vaccine hesitancy among MSM across multiple countries and regions.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Huachun Zou
- Numéro de téléphone: +86-21-54237707
- E-mail: zouhuachun@fudan.edu.cn
Sauvegarde des contacts de l'étude
- Nom: Feiyang Yin
- Numéro de téléphone: +86 18008631217
- E-mail: fyyin25@m.fudan.edu.cn
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Self-identify as MSM, with eligibility in certain participating countries and regions potentially extended to transgender women and non-binary individuals who have sexual relations with men, using the same questionnaire.
La description
Inclusion Criteria:
-
Participants will be eligible for the study if they meet all of the following conditions:
- Have resided in a participating country or region for at least six months.
- Are aged 18 years or older.
- Self-identify as MSM, with eligibility in certain participating countries and regions potentially extended to transgender women and non-binary individuals who have sexual relations with men, using the same questionnaire.
Exclusion Criteria:
-
Participants will be excluded if they meet any of the following conditions:
- Are aged under 18 years.
- Decline to participate in the study or fail to complete the informed consent process.
- Have not resided, or do not currently reside, in a participating country or region.
- Submit duplicate responses from the same IP address or device.
- Fail data quality checks, including automated or fraudulent submissions and failure to pass human verification procedures.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_ONLY
- Perspectives temporelles: CROSS_SECTIONAL
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Hommes ayant des rapports sexuels avec des hommes
|
No interventions because it is a observational cross-sectional study |
|
transgender women and non-binary individuals
transgender women and non-binary individuals who have sexual relations with men |
No interventions because it is a observational cross-sectional study |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Vaccine uptake
Délai: Baseline, at enrollment in this cross-sectional study
|
Percentage(%) of participants who have received at least one dose of HPV vaccine, assessed by self-reported vaccination history |
Baseline, at enrollment in this cross-sectional study
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Vaccine knowledge
Délai: Baseline, at enrollment in this cross-sectional study
|
Vaccine knowledge will be measured based on participants' scores on the vaccine knowledge items included in the study questionnaire, which will assess general vaccine knowledge and HPV vaccine-specific knowledge. Responses to individual items will be scored according to the predefined scoring criteria and summed to generate domain-specific knowledge scores. Higher scores indicate greater knowledge in the corresponding domain. |
Baseline, at enrollment in this cross-sectional study
|
|
Vaccine attitude
Délai: Baseline, at enrollment in this cross-sectional study
|
Vaccine attitudes will be measured based on participants' scores on the Vaccination Attitudes Examination Scale included in the study questionnaire, which assesses four dimensions of vaccination attitudes: mistrust of vaccine benefits, worries about unforeseen future effects, concerns about commercial profiteering, and preference for natural immunity. Responses to individual items will be scored according to the predefined scoring criteria and combined to generate an overall vaccine attitude score. Higher scores indicate more negative attitudes toward vaccination. |
Baseline, at enrollment in this cross-sectional study
|
|
Vaccine confidence
Délai: Baseline, at enrollment in this cross-sectional study
|
Vaccine confidence will be measured based on participants' scores on the Vaccine Confidence Index included in the study questionnaire, which assesses perceptions of vaccine importance, safety, effectiveness, and compatibility with religious beliefs. Responses to individual items will be scored according to the predefined scoring criteria and combined to generate an overall vaccine confidence score. Higher scores indicate greater confidence in vaccines. |
Baseline, at enrollment in this cross-sectional study
|
|
Vaccine hesitancy
Délai: Baseline, at enrollment in this cross-sectional study
|
Vaccine hesitancy will be measured based on participants' scores on the Vaccine Hesitancy Scale included in the study questionnaire. The scale assesses participants' perceptions of vaccine importance and effectiveness, trust in vaccine information and recommendations, perceived benefits of vaccination, and concerns about vaccine risks and adverse effects. Responses to individual items will be scored according to the predefined scoring criteria and summed to generate a total vaccine hesitancy score. Higher total scores indicate greater vaccine hesitancy. |
Baseline, at enrollment in this cross-sectional study
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- H2026163
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .